Connection

Olga Brawman-Mintzer to Antidepressive Agents

Back to Details
This is a "connection" page, showing publications Olga Brawman-Mintzer has written about Antidepressive Agents.
Olga Brawman-Mintzer
Connection Strength
0.725
Antidepressive Agents
  1. New trends in the treatment of anxiety disorders. CNS Spectr. 2004 Aug; 9(8 Suppl 7):19-27.
    View in: PubMed
    Score: 0.223
  2. The pharmacologic treatment of depression: is gender a critical factor? J Clin Psychiatry. 2002 Jul; 63(7):610-5.
    View in: PubMed
    Score: 0.193
  3. A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. J Clin Psychopharmacol. 2018 Aug; 38(4):336-343.
    View in: PubMed
    Score: 0.147
  4. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Affect Disord. 2016 Dec; 206:151-160.
    View in: PubMed
    Score: 0.127
  5. Anxious depression. J Clin Psychiatry. 1998; 59 Suppl 18:10-7.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.